LeMaitre Financial Statements From 2010 to 2026

LMAT Stock  USD 81.10  1.91  2.30%   
Analyzing historical trends in various income statement and balance sheet accounts from LeMaitre Vascular's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting LeMaitre Vascular's valuation are summarized below:
LeMaitre Vascular does not currently have any fundamental ratios for analysis.
Check LeMaitre Vascular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LeMaitre Vascular's main balance sheet or income statement drivers, such as , as well as many indicators such as . LeMaitre financial statements analysis is a perfect complement when working with LeMaitre Vascular Valuation or Volatility modules.
Check out the analysis of LeMaitre Vascular Correlation against competitors.
For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.

LeMaitre Vascular Company Return On Asset Analysis

LeMaitre Vascular's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current LeMaitre Vascular Return On Asset

    
  0.0794  
Most of LeMaitre Vascular's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LeMaitre Vascular is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, LeMaitre Vascular has a Return On Asset of 0.0794. This is 100.91% lower than that of the Health Care Equipment & Supplies sector and 100.27% lower than that of the Health Care industry. The return on asset for all United States stocks is 156.71% lower than that of the firm.

LeMaitre Vascular Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining LeMaitre Vascular's current stock value. Our valuation model uses many indicators to compare LeMaitre Vascular value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LeMaitre Vascular competition to find correlations between indicators driving LeMaitre Vascular's intrinsic value. More Info.
LeMaitre Vascular is rated third overall in return on equity category among its peers. It also is rated third overall in return on asset category among its peers reporting about  0.53  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for LeMaitre Vascular is roughly  1.89 . Comparative valuation analysis is a catch-all technique that is used if you cannot value LeMaitre Vascular by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

About LeMaitre Vascular Financial Statements

LeMaitre Vascular shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although LeMaitre Vascular investors may analyze each financial statement separately, they are all interrelated. The changes in LeMaitre Vascular's assets and liabilities, for example, are also reflected in the revenues and expenses on on LeMaitre Vascular's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Lemaitre Vascular operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 450 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for LeMaitre Stock Analysis

When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.